# 119-hr-7050: Homeopathic Drug Product Safety, Quality, and Transparency Act

119-hr-7050, Homeopathic Drug Product Safety, Quality, and Transparency Act, is a 119th Congress bill sponsored by Rep. Sessions, Pete [R-TX-17] (R-TX); status introduced; PRIA reads it as touching household money (as of 2026-09-21).

- Canonical: https://policyrisk.com/legislation/119-hr-7050
- As of: 2026-09-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-7050
- Congress: 119
- Title: Homeopathic Drug Product Safety, Quality, and Transparency Act
- Status: introduced
- Introduced: 2026-01-14
- Sponsor: Rep. Sessions, Pete [R-TX-17] (R-TX)
- Cosponsors: 6
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-09-21

## Summary

**This bill would create a distinct regulatory pathway for homeopathic drug products** and set rules on safety, quality, labeling, and oversight while preserving state authority over the practice of homeopathy. - Consumers and families would see clearer product information. Labels must state homeopathic status, include a mandatory adjacent disclaimer that the product's indications have not been evaluated by FDA, and show the source for each indication or link via QR code. - Manufacturers would face a tailored quality regime. The bill allows recognized homeopathic standards to govern adulteration and quality or a new homeopathy-specific good manufacturing practice. It bars premarket approval and creates a petition process with a 60-day advisory review and a 180-day decision clock that can lead to deemed approval. - Regulators and practitioners would get a dedicated advisory body and trained inspectors. A 10-member Homeopathic Drug Product Advisory Committee would advise on standards, meet quarterly, and review adverse event reports while inspectors must be knowledgeable about homeopathic standards.

## Cosponsors (6)

- Rep. Kennedy, Mike [R-UT-3] (R-UT), 2026-01-14T00:00:00.000Z
- Rep. Jackson, Jonathan L. [D-IL-1] (D-IL), 2026-01-14T00:00:00.000Z
- Rep. Owens, Burgess [R-UT-4] (R-UT), 2026-04-21T00:00:00.000Z
- Rep. Mills, Cory [R-FL-7] (R-FL), 2026-05-20T00:00:00.000Z
- Rep. Gosar, Paul A. [R-AZ-9] (R-AZ), 2026-07-20T00:00:00.000Z
- Rep. Cloud, Michael [R-TX-27] (R-TX), 2026-07-20T00:00:00.000Z

## Provisions PRIA read

- New rules for homeopathic products: mixed, low. If enacted, this bill would create a new, separate regulatory path for homeopathic drug products under the FDA law. It would bar FDA from requiring premarket approval for these products and would exempt finished homeopathic products from the usual identity-and-strength lab test while still requirin…

## Related bills

- 119-hr-9877: Health Equity and Accountability Act of 2026
- 119-hr-1628: 761st Tank Battalion Congressional Gold Medal Act
- 119-hr-452: Miracle on Ice Congressional Gold Medal Act
- 119-hr-9298: Stopping Harmful and Outrageous Torts Act
- 119-hr-1262: Mikaela Naylon Give Kids a Chance Act
- 119-hr-404: Hearing Protection Act

## Sources
- [119-hr-7050 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/7050)

## Related
- [119-hr-9877: Health Equity and Accountability Act of 2026](https://policyrisk.com/legislation/119-hr-9877)
- [119-hr-1628: 761st Tank Battalion Congressional Gold Medal Act](https://policyrisk.com/legislation/119-hr-1628)
- [119-hr-452: Miracle on Ice Congressional Gold Medal Act](https://policyrisk.com/legislation/119-hr-452)
- [119-hr-9298: Stopping Harmful and Outrageous Torts Act](https://policyrisk.com/legislation/119-hr-9298)
- [119-hr-1262: Mikaela Naylon Give Kids a Chance Act](https://policyrisk.com/legislation/119-hr-1262)
- [119-hr-404: Hearing Protection Act](https://policyrisk.com/legislation/119-hr-404)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-7050 (as of 2026-09-21).